Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beigene | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥239.79B | -61.7x | -1.8 | CN¥267.40 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.3% Upside | Upgrade to Pro+ | |
WuXi AppTec | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥195.03B | 17.7x | -0.94 | CN¥67.71 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24% Upside | Upgrade to Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥43.97B | 137.4x | -1.63 | CN¥53.61 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5% Upside | Upgrade to Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥43.20B | 0.41 | CN¥96.01 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | ||
Pharmaron Beijing | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥42.21B | 24x | 0.85 | CN¥25.47 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.1% Upside | Upgrade to Pro+ | |
RemeGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥35.79B | -16.5x | -2.34 | CN¥71 | 17.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -35.2% Downside | Upgrade to Pro+ | |
Dizal Jiangsu Pharmaceutical | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥30.47B | -28.5x | -1.41 | CN¥66.33 | 6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.5% Upside | Upgrade to Pro+ | |
InnoCare Pharma | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥25.65B | -57.9x | -3.37 | CN¥27.29 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sinocelltech Group | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥21.90B | 172.9x | 1.39 | CN¥49.18 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.8% Upside | Upgrade to Pro+ | |
InventisBio | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥20.70B | -54.2x | -7.28 | CN¥35.80 | 6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -20.4% Downside | Upgrade to Pro+ | |
BGI Genomics | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥19.62B | -22.9x | 0.01 | CN¥51.11 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Joinn Laboratories China | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥14.30B | 39.9x | 0.05 | CN¥20.32 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.1% Downside | Upgrade to Pro+ | |
Mabwell Shanghai Bioscience | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥11.82B | -7.1x | 0.94 | CN¥29.57 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.5% Upside | Upgrade to Pro+ | |
Bio-Thera Solutions | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥11.37B | -18.3x | 0.77 | CN¥27.47 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
Sino Biological | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥8.05B | 75.6x | -1.5 | CN¥66.20 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.8% Upside | Upgrade to Pro+ | |
HitGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.76B | 97.6x | 10.71 | CN¥16.92 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.2% Downside | Upgrade to Pro+ | |
ChemPartner PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥6.42B | -27.1x | -0.41 | CN¥12.89 | 11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shouyao Holdings Beijing | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.38B | -24.3x | 3.28 | CN¥42.91 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.2% Upside | Upgrade to Pro+ | |
Beijing Sun Novo Pharmaceutical Research | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.84B | 45.3x | -1.2 | CN¥53.40 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hinova Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.59B | -23.7x | -0.97 | CN¥56.46 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.7% Upside | Upgrade to Pro+ | |
Jiangsu Asieris Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.33B | -13.1x | -1.67 | CN¥9.50 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.4% Upside | Upgrade to Pro+ | |
GemPharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.30B | 46.8x | -1.68 | CN¥13.01 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.6% Upside | Upgrade to Pro+ | |
R G PharmaStudies | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥5.03B | 30.5x | -1.39 | CN¥52.85 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.4% Upside | Upgrade to Pro+ | |
Hangzhou BioSincerity PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.97B | -29.3x | 0.27 | CN¥45.84 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaResources Shanghai | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.80B | 183.2x | -19.82 | CN¥34.90 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Kawin Technology Shareholding Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.79B | 31.1x | 2.36 | CN¥28.59 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shanghai Medicilon | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.77B | -14x | 0.02 | CN¥35.65 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bide Pharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.54B | 30.5x | 1.45 | CN¥51.77 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.4% Downside | Upgrade to Pro+ | |
Shanghai Aladdin Biochemical Technology Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.10B | 38x | 2.37 | CN¥12.39 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.8% Downside | Upgrade to Pro+ | |
Guangzhou Boji Medical & Biotech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.60B | 209.5x | -4.88 | CN¥9.46 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Qingdao Vland Biotech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.52B | 57.3x | -2.16 | CN¥13.90 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.1% Upside | Upgrade to Pro+ | |
Anhui Wanbang Pharmaceutical | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.09B | 37.1x | -0.96 | CN¥46.39 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Xinjiang Baihuacun | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥2.99B | 63.8x | 1.36 | CN¥7.79 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |